Calogen

DIETARY_SUPPLEMENT2 trials

Sponsors

University of Ulm, Technological Educational Institute of Thessaly

Conditions

Amyotrophic Lateral SclerosisDumping Syndrome

Unknown Phase

Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis

CompletedNCT02306590

University of UlmAmyotrophic Lateral Sclerosis

Start: 2015-02-28End: 2018-09-30Updated: 2019-02-26

Fat Supplementation on Dumping Syndrome Associated Symptoms

Technological Educational Institute of ThessalyDumping Syndrome

Start: 2017-09-12End: 2023-04-30Target: 25Updated: 2022-11-15

Related Papers

Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.

2021-08-2633 citations

Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis?

Neural Regeneration Research2020-01-014 citations

Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS.

2019-05-2916 citations